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Abstract:  B-mode ultrasonography of the carotid artery is a non-invasive, informative and reproducible  technique   
used for the assessment of prevalence and course of atherosclerosis in a variety of clinical conditions. Visualization of  
intima-media complex, atherosclerotic plaques, rough arterial wall and calcifications of the carotid artery may be useful 
for the assessment of atherosclerotic burden. The latter was confirmed in a recent consensus statement of the American 
Society of Echocardiography. Detection of structural changes, such as Menkeber’s sclerosis of the medial layer of the  
carotid artery, carotid aneurysm may indicate advanced vascular pathology and prompt an appropriate treatment.   
Ultrasound images of patients with atherosclerotic plaque and Menkeberg’s sclerosis are presented and issues related to 
clinical significance of the common carotid artery intima-media thickness are discussed. 
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INTRODUCTION 
  B-mode ultrasonography of the carotid artery is   
nowadays increasingly used as a non-invasive and well-
validated tool for assessment of atherosclerotic burden in a 
variety of clinical conditions [1]. It is believed that it can be 
used for both research and clinical purposes. 
  Atherosclerotic changes in the carotid artery (e.g., thick-
ened intima-media complex, presence of plaques, rough arte-
rial wall, calcifications) and other structural abnormalities 
detected by high-resolution ultrasound have been shown to 
be strongly associated with a number of classic cardiovascu-
lar risk factors [2,3]. A prime example  of this association 
is an increased prevalence of carotid plaques in patients with 
familial hypercholesterolemia and arterial hypertension   
(Fig. 1), warranting further investigations to assess the level 
of the carotid artery stenosis and tightening of lipid-
lowering, anti-hypertensive therapy and/or invasive surgical 
procedures. It should be emphasized that in the case of   
familial hypercholesterolemia visualization of substantial 
changes in carotid arteries such as atherosclerotic plaques 
may prompt the clinician to use ultrasound to search   
for other pathophysiologically related changes at other   
anatomical sites (e.g., Achilles tendon thickening) [4].  
  Evidence from a few well-designed, large scale prospec-
tive studies suggests that non-invasively measured intima-
media thickness (IMT)  of the common carotid artery   
may predict occurrence of cardiovascular events in subjects 
without clinical manifestations of ischemic heart disease or 
cerebrovascular disease [2, 5] and in those with established 
cardiovascular disease [6]. Obviously, IMT values can be   
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supplementary to cardiovascular risk assessments based   
on traditional risk factors and useful for  cardiovascular   
drugs clinical efficiency assessments. Of note, in prospective 
studies with statins, carotid IMT proved to be essential for 
monitoring of the course of atherosclerotic vascular disease 
[7, 8]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Huge atherosclerotic plaque in the common carotid artery 
in a 77-yo Caucasian male patient with arterial hypertension,   
vertigo and carotid artery stenosis (60%).  
  The latest consensus statement of the American Society 
of Echocardiography [9], based on the analysis of several 
prospective studies, confirmed that carotid IMT measured by 
high-resolution B-mode carotid ultrasound  is a well-
validated tool for detecting subclinical atherosclerosis and 
defining cardiovascular risk profile in conditions with low 
and high vascular risk. From practical standpoint, for the 
first time the statement firmly pointed out that the interpreta-
tion of IMT measurements should take into account age, sex,  
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ethnicity, underlying clinical conditions (e.g., diabetes,   
peripheral vascular disease), duration and aggressiveness of 
cardiovascular drug treatments,  notably with statins, 
and  carotid scanning technique. The latter requires special 
professional skills and computer software, which can   
substantially improve accuracy of the lumen-intima interface 
detection and IMT measurement, and should be seen as a 
prerequisite of research studies. Accuracy of the measure-
ment can be further improved by synchronized electrocar-
diography and R wave gating. Another practically important 
point in the statement was that far wall of the common   
carotid artery is the most appropriate site for IMT measure-
ment, compared with other  vascular sites. Calculation of 
IMT, however, should be mandatory accompanied by careful 
visualization of the whole system of extracranial carotid   
arteries to rule in or out presence of atherosclerotic plaques. 
  Outlined in the consensus statement the issue of   
age-related changes in the carotid arteries are of importance 
for further research studies, since it is well-known that   
predictive value of IMT and carotid plaques at a relatively 
young age (below 45)  is still uncertain. However, more   
prospective studies are warranted to ascertain association 
between atherosclerotic changes of carotid arteries and hard 
points such as MI, stroke and death in different age groups. 
  It is also worth noting that there are uncertainties over the 
interpretation of IMT measurements and accuracy of cardio-
vascular risk calculation in diabetes mellitus and other low- 
or high-grade inflammatory disorders. The problem relates to 
the origin of structural changes in these clinical conditions. 
Atherosclerotic and inflammatory changes of the carotid 
artery are  closely related and  may  alter the structure of   
intima-media complex in diverse directions. For example, in 
diabetes, disease-specific changes of the medial layer of the 
carotid artery, known as Menkeberg's  sclerosis,  may occur 
(Fig. 2), which further complicate interpretation of the value 
of IMT. Menkeberg's sclerosis  reflects  diabetic vascular   
pathology caused by long-standing underlying disease and, 
even if there is normal or slightly increased IMT, such as in 
the presented case, high risk of future cardiovascular events 
is obvious. 
  The impact of chronic inflammation on IMT of the   
carotid artery and the meaning of increased IMT in  high-
grade inflammatory diseases such as rheumatoid arthritis and 
systemic lupus erythematosus  is another big issue, which, 
unfortunately, has not been covered in the statement. 
  It is believed  that an increased IMT is a reflection of   
subclinical and accelerated atherosclerosis  in chronic   
inflammatory conditions. However, it appears that links   
between inflammation and IMT are not straightforward.   
Although positive association of a variety of inflammatory 
biomarkers (first of all, C reactive protein and fibrinogen) 
with carotid IMT have been found in the vast majority of 
observational studies [10], there are also few negative publi-
cations [11], and it is still not clear whether an increase of 
IMT  may independently predict cardiovascular events in 
high-grade inflammatory conditions [12]. Assessment of 
clinical efficiency and anti-atherosclerotic effects of widely 
used  in these conditions anti-inflammatory and lipid-
lowering drugs (e.g., anti-TNFalpha drugs and statins) based 
on IMT values over the course of short- and long-term   
 
treatment is questionable. In this regard, a number of factors 
potentially influencing IMT values should be carefully 
weighed (e.g., duration and activity of an inflammatory   
disorder). A decrease of IMT over a short period of time 
(days-weeks) is most probably due to the dampening   
inflammation in the vascular wall rather than anti-
atherosclerotic effect of treatment. In fact, recently published 
results of the Measuring Effects on intima media Thickness: 
an Evaluation Of Rosuvastatin (METEOR) trial come to 
prove that the use of carotid ultrasound for assessment of 
anti-atherosclerotic effects of a drug treatment is justified 
when repetitive measurements over a long period of time   
(at least 12 months) are available [13].  
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Carotid ultrasonography of a 72-yo Caucasian female   
patient with a history of poorly contolled type 2 diabetes mellitus 
[duration - 38 years; fasting blood glucose - 283 mg/dL (reference 
range - 55-105 mg/dL) and glycosilated hemoglobin A1c - 10.8% 
(3.4-6.1%)]. IMT of the common carotid artery is 1.3 mm; hypere-
chogeneity of the medial layer (suggestive of Menkeberg's medial 
sclerosis), soft plaques in bifurcation of the catorid artery; no signs 
of carotid stenosis. 
  Further long-term prospective studies are needed to   
address this issue in the context of high-grade inflammatory 
disorders and provide us with the clues over clinical signifi-
cance of IMT changes in different clinical conditions. The 
latter may  also lead to  specific recommendations  on the   
routine use of carotid ultrasound in clinical practice. 
  Carotid ultrasound assessments of atherosclerotic burden 
have been relatively well studied.  Nevertheless, the use of 
this important tool may be further expanded towards detect-
ing non-atherosclerotic changes as well. An appropriate   
example is carotid pathology in Behcet's disease, where   
visualization of the carotid aneurysm may indicate aggresive 
course of the disease and prompt further investigations to 
search for other sites of aneurysmatic vascular affections and 
proper treatment [14, 15]. 
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